Cuprina Holdings Cayman Limited Quick Ratio (CUPR) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Cuprina Holdings cayman Limited  (NASDAQ: CUPR)

Cuprina Holdings Cayman Limited's Quick Ratio

CUPR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Cuprina Holdings Cayman Limited's Cash & cash equivalent grew by 2.78 % in the Q4 2025 sequentially, while Current Liabilities decreased, this led to improvement in Cuprina Holdings Cayman Limited's Quick Ratio to 1.03, Quick Ratio remained below Cuprina Holdings cayman Limited average.

Within Medical Equipment & Supplies industry 119 other companies have achieved higher Quick Ratio than Cuprina Holdings Cayman Limited in fourth quarter 2025. While Quick Ratio total ranking has improved so far during the Q4 2025 to 2076, from total ranking in the third quarter 2025 at 4324.

Explain Quick Ratio?
How much Cash & cash equivalents CUPR´s has?
What are CUPR´s Current Liabilities?




CUPR Quick Ratio (Dec 31 2025)
Q4
0
Q3
0
Q2
0
Q1
(Dec 31 2024)
Q4
Y / Y Current Liabilities Change -48.24 % -45.46 % -98.87 % -45.46 % 39.49 %
Y / Y Cash & cash equivalent Change 1752.76 % 2730.77 % 3719.66 % 2730.77 % 73.99 %
Quick Ratio MRQ 1.03 1 65.14 1 0.03
CUPR's Total Ranking # 2076 # 4324 # # #
Seq. Current Liabilities Change 0 % 4724.41 % -97.93 % -48.24 % 5.36 %
Seq. Cash & cash equivalent Change 2.78 % -25.89 % 34.93 % 1702.67 % 57.03 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 676
Overall Market # 2076


Quick Ratio Statistics
High Average Low
65.14 8.53 0.02
0  




Financial Statements
Cuprina Holdings Cayman Limited's Current Liabilities $ 2 Millions Visit CUPR's Balance sheet
Cuprina Holdings Cayman Limited's Cash & cash equivalent $ 2 Millions Visit CUPR's Balance sheet
Source of CUPR's Sales Visit CUPR's Sales by Geography


Cumulative Cuprina Holdings Cayman Limited's Quick Ratio

CUPR's Quick Ratio for the trailling 12 Months

CUPR Quick Ratio

(Dec 31 2025)
12 Months
0
12 Months
0
12 Months
0
12 Months
(Dec 31 2024)
12 Months
Y / Y Current Liabilities TTM Growth -59.36 % -42.6 % -5.26 % 105.03 % 436.67 %
Y / Y Cash & cash equivalent TTM Growth 2611.1 % 2369.73 % 2279.8 % 1575.55 % 406.39 %
Quick Ratio TTM 1.45 0.86 0.51 0.17 0.02
Total Ranking TTM # 4665 # 3782 # # #
Seq. Current Liabilities TTM Growth -23.58 % -17.42 % -27.47 % -11.22 % 7.94 %
Seq. Cash & cash equivalent TTM Growth 28.56 % 39.53 % 116.68 % 597.5 % 17.11 %


On the trailing twelve months basis CUPR Cash & cash equivalent more than doubled by 1752.76 % in Q4 2025 year on year, while Current Liabilities remained unchanged to $2 millions, this led to increase in in Cuprina Holdings Cayman Limited's Quick Ratio to 1.45, above CUPR average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 217 other companies have achieved higher Quick Ratio than Cuprina Holdings Cayman Limited. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from 3782 to 4665.

Explain Quick Ratio?
How much Cash & cash equivalents CUPR´s has?
What are CUPR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 218
Healthcare Sector # 994
Within the Market # 4665


trailing twelve months Quick Ratio Statistics
High Average Low
1.1 0.56 0.02
(Dec 31 2025)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Glaukos Corp  2.75 $ 278.760  Millions$ 101.275  Millions
Staar Surgical Co  2.74 $ 187.536  Millions$ 68.504  Millions
Apyx Medical Corp  2.71 $ 31.740  Millions$ 11.700  Millions
Adagio Medical Holdings inc   2.65 $ 20.586  Millions$ 7.763  Millions
Mimedx Group Inc   2.58 $ 166.121  Millions$ 64.266  Millions
Axe Compute Inc  2.53 $ 10.791  Millions$ 4.267  Millions
Longduoduo Co Ltd  2.47 $ 0.968  Millions$ 0.393  Millions
Vivani Medical Inc   2.46 $ 16.232  Millions$ 6.602  Millions
Dariohealth Corp   2.36 $ 22.032  Millions$ 9.323  Millions
Capsovision Inc   2.28 $ 10.112  Millions$ 4.427  Millions
Sharps Technology Inc   2.21 $ 10.383  Millions$ 4.695  Millions
Tactile Systems Technology Inc   2.21 $ 83.446  Millions$ 37.762  Millions
Myomo Inc   2.20 $ 18.394  Millions$ 8.345  Millions
Inogen Inc   2.18 $ 119.577  Millions$ 54.869  Millions
Atricure Inc   2.05 $ 167.428  Millions$ 81.520  Millions
Edwards Lifesciences Corporation  1.99 $ 5,526.800  Millions$ 2,773.600  Millions
Axogen inc   1.96 $ 41.528  Millions$ 21.184  Millions
Nephros Inc   1.95 $ 5.400  Millions$ 2.767  Millions
Merit Medical Systems Inc  1.95 $ 446.404  Millions$ 228.888  Millions
Polypid Ltd  1.93 $ 13.126  Millions$ 6.786  Millions
Warby Parker Inc   1.91 $ 286.358  Millions$ 150.130  Millions
Medinotec Inc   1.88 $ 2.770  Millions$ 1.477  Millions
Vaso Corporation  1.84 $ 34.081  Millions$ 18.497  Millions
Neuraxis Inc   1.83 $ 4.965  Millions$ 2.710  Millions
Trisalus Life Sciences Inc   1.78 $ 20.439  Millions$ 11.499  Millions
Pulsenmore Ltd   1.75 $ 6.773  Millions$ 3.860  Millions
Si bone inc   1.74 $ 42.240  Millions$ 24.335  Millions
Genedx Holdings Corp   1.64 $ 171.282  Millions$ 104.504  Millions
Treace Medical Concepts Inc   1.58 $ 48.367  Millions$ 30.635  Millions
Glucotrack Inc   1.55 $ 7.383  Millions$ 4.773  Millions

Date modified: 2026-09-08T15:11:40+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.